Bank of New York Mellon’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bank of New York Mellon’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-41,484	Closed	-$1.01M	–	4480
2017 Q4	$1.01M	Buy	41,484 +1,306	+3%	+$25.1K	﹤0.01%	3240
2017 Q3	$742K	Sell	40,178 -605	-1%	-$10.5K	﹤0.01%	3395
2017 Q2	$675K	Buy	40,783 +9,270	+29%	+$129K	﹤0.01%	3459
2017 Q1	$434K	Sell	31,513 -810	-3%	-$13K	﹤0.01%	3604
2016 Q4	$613K	Buy	32,323 +3,122	+11%	+$59.9K	﹤0.01%	3498
2016 Q3	$647K	Sell	29,201 -1,106	-4%	-$20.8K	﹤0.01%	3408
2016 Q2	$554K	Buy	30,307 +4,960	+20%	+$85.4K	﹤0.01%	3485
2016 Q1	$461K	Hold	25,347	–	–	﹤0.01%	3478
2015 Q4	$427K	Hold	25,347	–	–	﹤0.01%	3597
2015 Q3	$456K	Buy	25,347 +950	+4%	+$21.2K	﹤0.01%	3617
2015 Q2	$631K	Buy	24,397 +11,788	+93%	+$298K	﹤0.01%	3557
2015 Q1	$276K	Buy	+12,609	New	+$272K	﹤0.01%	3808

Bank of New York Mellon's ENTL Position: Q1 2018 in Review

Bank of New York Mellon sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 41,484 shares — an estimated $1.01M sold.

Bank of New York Mellon first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $1.01M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Bank of New York Mellon reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Bank of New York Mellon sold 41,484 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.01M.
Bank of New York Mellon first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
Bank of New York Mellon's Entellus Medical, Inc. Common Stock position peaked at $1.01M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.